Postpartum Hemorrhage (PPH) Devices Market Overview
Global Postpartum Hemorrhage (PPH) Devices Market was valued at $637 million in 2015, and is expected to reach $906 million by 2022 supported by a CAGR of 5.2% during the forecast period 2016 to 2022. Postpartum hemorrhage is the most common form of obstetric hemorrhage and is one of the leading cause of maternal mortality. According to the data revealed by WHO, about one quarter of the maternal deaths occur due to postpartum hemorrhage. Postpartum hemorrhage is classified as primary PPH where blood loss is less than 500 ml and secondary PPH having blood loss more than 500ml. Currently, active management of third labor is practiced for preventing PPH which is administered directly after the child birth.
PPH can be treated by first line (non-surgical) methods which involves the adoption of uterotonic drugs such as oxytocin and misoprostol. However, in the absence of drugs, second line intervention devices are adopted such as non-pneumatic anti-shock garment, Uterine balloon tamponade and Uniject prefilled injection systems. Since these devices are effective in stopping the blood flow and stabilize the condition of the patient until substantive care is provided.
The key drivers for the market growth are rising pregnancy complications such as multiple pregnancies, inverted uterus and large size of the baby. Moreover, rising postpartum hemorrhage risk factors such as uterine atony, trauma, rising anaemia cases in pregnant women and technological advancements such as capability of the devices to stabilize the condition of the patient until permanent treatment is provided are fueling the market growth. However, dearth of healthcare services in developing countries and high cost of the devices are expected to hinder the growth of this market.
Top Impacting Factors in Global PPH Market
Anaemia, a serious nutrition problem, is one of the reasons of postpartum hemorrhage in pregnant women. According to an article published in 2008 by NCBI, data demonstrated that severe anemia may weaken the immune system thereby contributing to postpartum hemorrhage. Moreover, anemia increases the risk of blood clotting disorders which multiplies the chances of postpartum hemorrhage.
Severity of Anaemia in Pregnancy in the Primary Healthcare
South Korea is one of the attractive markets in the global postpartum hemorrhage devices market. Increasing healthcare expenditure and better focus on the development of cost-effective PPH preventive devices have led to its increased market potential for the postpartum hemorrhage devices in the country. Rising number of cases of pregnancy related cases and increasing risk factors causing postpartum hemorrhage are driving the growth of this market. Thus, South Korea is a potential and emerging market for growth of postpartum hemorrhage products.
South Korea: PPH Devices Market, 2014‐2022 ($Million)
Uterine balloon tamponade is a simple and effective second line intervention treatment for PPH. Many healthcare organizations such as global Health Organization (WHO), International Confederation of Midwives (ICM) and International Federation of Gynecology and Obstetrics (FIGO) have involved uterine balloon tamponade as a method to improve the management of PPH. Besides, the device can be even used in low resource settings which is the main reason for the increase in its demand. These devices can be used for PPH caused due to uterine atony as well as for postabortion care and placenta previa. Several balloon tamponade devices have been used in the treatment and management of PPH such as Bakri balloon tamponade, Foley catheter, Condom catheter and Rusch balloon.
Uterine Balloon Tamponade Devices Market, 2014‐2022 ($Million)
The report also provides company profiles of major players operating in the global postpartum hemorrhage devices market such as Utah Medical Products, Inc., C. R. Bard, Inc., Cook Medical, Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Bactiguard AB, Program for Appropriate Technology in Health (PATH), 3RD Stone Design, Inc., Zoex Niasg, Vitality Medical, Revmedx Inc. and Inpress Technologies.
PPH DEVICES MARKET KEY BENEFITS
- The study provides an in-depth analysis of the global postpartum hemorrhage devices market, with current trends and future estimations, to elucidate the imminent investment pockets
- The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities
- The report provides actual historical figures for 2014 and Y-o-Y forecasts from 2016 to 2022, considering 2015 as base.
- Competitive intelligence highlights the business practices followed by leading players across various regions
- Comprehensive analysis of all geographic regions are provided to determine the prevailing opportunities in these geographies.
- Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
PPH DEVICES MARKET KEY MARKET SEGMENTS
The global PPH devices market is segmented based on product, and geography.
- Non-Pneumatic Anti-Shock Garment
- Uniject Prefilled Injection System
- Uterine Balloon Tamponade
- Foley Catheter
- Condom Catheter
- Bakri balloon tamponade
- BT-Cath balloon
- Rusch balloon
- North America
- Rest of Europe
- South Korea
- Rest of APAC
- South Africa
- Saudi Arabia
- Rest of LAMEA